Shan Luan, Ph.D., Mba Email & Phone Number

Wilmington, Delaware, United States

Shanghai, China

Shanghai, China

Wilmington, Delaware

• Led the project of defining the BRILINTA Mechanism Of Action (MOA) in reducing recurrent CV events in post-MI patients for 600 sales specialists and 2019 Core Visual Aid, and was granted approval by Promotional.
• Explored and presented the possible FARXIGA MOAs for Diabetes Life Cycle Management Team for the preparation of DECLARE to be launched in September 2018
• Worked with HR team on branding Commercial Leadership Development Program (CLDP). This included being named the MBA intern spokesperson for the Consortium Conference, interviewing/filming 6 executives regarding the MBA.

Pittsburgh

• Selected by the Dean of Public Health and Innovation Institute to conduct market research and customer discovery for commercialization of a disease epidemiology model FRED
• Competed among 42 teams at 2018 Rice Business Plan Competition, the world's largest student startup competition, to attract venture capitalists

Pittsburgh

• Worked a diverse Katz team which was judged a McKinsey Cup Competition finalist
• Collaborated with 13 senior executives to create global workforce productivity metrics assessing the effectiveness of 15 communication application tools that will be implemented by the Technology Services Department in.

Pittsburgh

• Appointment in Professor Gary Thomas Lab
• Established a novel mouse model to study obesity, which provided insight into the cause of obesity and cardiovascular disease and will potentially impact the $300B healthcare market and 40% of the US population
• Determined the function of an activating compound for an obesity-controlling enzyme in a mouse model for a global pharmaceutical firm, therefore enhancing its safety profile in a $8B market
• Received SPRIG Scholar's Pilot Project Award (in the pool of 200 applicants) in the amount of total 40K for two years. This highly selective award is given based on project novelty, practical significance and the.
• Collaborated with researchers at leading biomedical research facilities and presented research at regional seminars
• Co-authored 2 peer reviewed publications

Saint Louis, MO

• Appointment in Professor William Sly Lab
• Developed a new drug delivery system for treatment of Mucopolysaccharidosis type 7 (MPS7, also called Sly syndrome – a rare genetic disorder with no known treatment), which will benefit about 200 patients in the US
• Determined the efficacy of a leading MPS7 treatment for a pharmaceutical firm using β-glucuronidase deficient mice. Reduced the initial expected costs of clinical trials by ~30%
• Participated in consulting engagement to evaluate the safety of a potential treatment for MPS7 with an expected market value of over $100M. Contributed to presentation of the findings to the client’s senior management
• Co-authored 1 peer reviewed publication

St. Louis, MO

• Appointment in William Stark and Joel Eissenberg Lab
• Studied the role of cellular protein trafficking in fruit flies as a model organism in order to understand its functions in human diseases.
• Instructed 150 undergraduate students over the course of two semesters. Established effective leadership, time managing, problem solving and communication skills.
• Authored and co-authored 3 peer reviewed publications

Shenzhen, China

• Served as patients’ advocate and translator for 2 international patients receiving gene therapy for cancer treatments and helped to establish implementation of phase III clinical trials in Shenzhen Hospital

London, England

• Appointment at Jodrell Laboratory
• Identified and analyzed the chemical components of over 3000 medicinal plants for the British Pharmacopeia

Master Of Business Administration - Mba, Marketing And Finance

Activities and Societies: Nominee to Poet and Quant “Best and Brightest”, Jacqueline Graham Student Fund (Merit-based), Wilma F. Tabisz.

Doctor Of Philosophy (Ph.D.), Biology

Bachelor Of Applied Science (B.A.Sc.) (2I), Molecular And Celluar Biology